Friday, October 28, 2011

AstraZeneca indicted in Serbian corruption case, it's just business as usual

AstraZeneca business as usual news from the Seroquel Lawsuit Blog , it seems that AstraZeneca, the pharma giant and maker of antipsychotic Seroquel is at it again with DoJ investigations, and indictments for alleged bribery and improper payments to Serbian doctors, that all on the heels of the 3rd quarter earnings report where it states AstraZeneca has spent $759 million dollars in its defense for the Seroquel diabetes lawsuits.


Check out the links for some good, criminal reading!

0 comments: